Hologic Gains HPV Test Technology In $580 Million Third Wave Purchase

Hologic's purchase of molecular diagnostics firm Third Wave Technologies for $580 million provides a platform for near-term entry into the expanding, $200 million U.S. market for human papillomavirus testing